StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30
$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Cryo-Cell International's enterprise value was $45.25M on Nov 11, 2026, against $39.62M a year earlier. Over the last 5 years it ranged from $30.92M to $91.17M, with a median of $49.43M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$45.25M+38.4%
2025Dec 31, 2025$32.69M-50.4%
2024Dec 31, 2024$65.94M+20.1%
2023Dec 29, 2023$54.91M+31.7%
2022Dec 30, 2022$41.71M-54.3%
2021Dec 31, 2021$91.17M+70.3%
2020Dec 31, 2020$53.53M-0.9%
2019Dec 31, 2019$54.03M+4.0%
2018Dec 31, 2018$51.94M-19.9%
2017Dec 29, 2017$64.87M+117.0%
2016Dec 30, 2016$29.89M+6.1%
2015Dec 31, 2015$28.17M+23.6%
2014Dec 31, 2014$22.79M+23.1%
2013Dec 31, 2013$18.51M-19.6%
2012Dec 31, 2012$23.02M+12.8%
2011Dec 30, 2011$20.40M–

More Cryo-Cell International figures

See a number that looks wrong?